Outset Medical Inc (OM) - Net Assets
Based on the latest financial reports, Outset Medical Inc (OM) has net assets worth $96.34 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($242.38 Million) and total liabilities ($146.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Outset Medical Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $96.34 Million |
| % of Total Assets | 39.75% |
| Annual Growth Rate | N/A |
| 5-Year Change | -66.06% |
| 10-Year Change | N/A |
| Growth Volatility | 166.9 |
Outset Medical Inc - Net Assets Trend (2018–2025)
This chart illustrates how Outset Medical Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Outset Medical Inc stock valuation.
Annual Net Assets for Outset Medical Inc (2018–2025)
The table below shows the annual net assets of Outset Medical Inc from 2018 to 2025. Also explore OM shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $126.95 Million | +373.37% |
| 2024-12-31 | $26.82 Million | -78.18% |
| 2023-12-31 | $122.89 Million | -50.04% |
| 2022-12-31 | $245.99 Million | -34.24% |
| 2021-12-31 | $374.08 Million | +13.84% |
| 2020-12-31 | $328.61 Million | +188.29% |
| 2019-12-31 | $-372.19 Million | -29.25% |
| 2018-12-31 | $-287.95 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Outset Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 88348500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $18.00K | 0.01% |
| Other Comprehensive Income | $172.00K | 0.14% |
| Other Components | $1.30 Billion | 1022.54% |
| Total Equity | $126.95 Million | 100.00% |
Outset Medical Inc Competitors by Market Cap
The table below lists competitors of Outset Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Inversa Prime SOCIMI S.A.
MC:YIPS
|
$59.22 Million |
|
Newfield Resources Ltd
AU:NWF
|
$59.24 Million |
|
Samwon Steel
KO:023000
|
$59.25 Million |
|
Introl S.A.
WAR:INL
|
$59.28 Million |
|
Neontech Co. Ltd
KQ:306620
|
$59.21 Million |
|
EQL PHARMA AB
F:7JK
|
$59.21 Million |
|
Lida Holdings Ltd
TW:4552
|
$59.21 Million |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
$59.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Outset Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 26,819,000 to 126,952,000, a change of 100,133,000 (373.4%).
- Net loss of 81,653,000 reduced equity.
- New share issuances of 161,548,000 increased equity.
- Other comprehensive income increased equity by 130,000.
- Other factors increased equity by 20,108,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-81.65 Million | -64.32% |
| Share Issuances | $161.55 Million | +127.25% |
| Other Comprehensive Income | $130.00K | +0.1% |
| Other Changes | $20.11 Million | +15.84% |
| Total Change | $- | 373.37% |
Book Value vs Market Value Analysis
This analysis compares Outset Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.38x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-143.58 | $3.15 | x |
| 2019-12-31 | $-185.58 | $3.15 | x |
| 2020-12-31 | $115.38 | $3.15 | x |
| 2021-12-31 | $123.08 | $3.15 | x |
| 2022-12-31 | $76.61 | $3.15 | x |
| 2023-12-31 | $37.17 | $3.15 | x |
| 2024-12-31 | $7.74 | $3.15 | x |
| 2025-12-31 | $8.35 | $3.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Outset Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -64.32%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -68.34%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 2.08x
- Recent ROE (-64.32%) is above the historical average (-102.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -2480.32% | 0.01x | 0.00x | $-20.98 Million |
| 2019 | 0.00% | -452.97% | 0.17x | 0.00x | $-31.08 Million |
| 2020 | -36.73% | -241.71% | 0.12x | 1.23x | $-153.56 Million |
| 2021 | -35.27% | -128.59% | 0.22x | 1.24x | $-169.34 Million |
| 2022 | -66.24% | -141.24% | 0.29x | 1.63x | $-187.56 Million |
| 2023 | -140.62% | -132.54% | 0.42x | 2.55x | $-185.09 Million |
| 2024 | -477.18% | -112.57% | 0.41x | 10.28x | $-130.66 Million |
| 2025 | -64.32% | -68.34% | 0.45x | 2.08x | $-94.35 Million |
Industry Comparison
This section compares Outset Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Outset Medical Inc (OM) | $96.34 Million | 0.00% | 1.52x | $59.21 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more